Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZON-PFT: Zoledronic Acid in Postmenopausal Osteoporosis
NCT00049829Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2002
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Novartis. Started Jan 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00049829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049829.